Iontophoretic drug delivery packaging

Patent metadata

Field	Value
Publication number	US-9492650-B2
Application number	US-59795009-A
Country	US
Kind code	B2
Filing date	Sep 3, 2009
Priority date	Sep 5, 2008
Publication date	Nov 15, 2016
Grant date	Nov 15, 2016

Abstract

The present invention relates generally to iontophoretic drug delivery systems for transdermal delivery of therapeutic agents and, more particularly, to packaging such systems for long shelf life and easy assembly for use. The system package includes an iontophoretic skin worn patch component that accommodates a power source, electronics, electrodes and a drug pack component that carries a therapeutic agent which is contained as a separate sealed component. The packaged system further provides for ease of assembly at the time of use.

First claim

What is claimed is:

1. An iontophoretic drug delivery system for pre-use assembly comprising:
(a) a drug pack component comprising one or more gel pads;
(b) an iontophoresis patch component;
(c) wherein said iontophoresis patch component is configured to align said gel pads of said drug pack component in conductive relation in an assembled state; and
(d) an alignment structure to assist in assembling said components, wherein said alignment structure is selected from;
(1) a folding support structure associated with said drug pack component and said iontophoresis patch component, said folding support structure comprising a separator component configured to be interposed between and thereby physically separate and protect said drug pack and iontophoresis patch components when said iontophoretic drug delivery system is present in a fully folded storage stage,
wherein said folding support structure comprises a first panel having thereon said iontophoresis patch component, and a second panel having thereon said drug pack component comprising said gel gads and joined to said first panel on a first side of said second panel, and wherein said separator component comprises a third panel joined to said second panel on a second side of said second panel that is opposite said first side; and
(2) a guide element for separate consecutive alignment of said drug pack component with said iontophoresis patch component;
wherein said drug pack component comprises a drug pack support structure separate from the alignment structure, said iontophoresis patch component comprises an iontophoresis patch support structure separate from the alignment structure, and said alignment structure comprising said guide element comprises a flat substrate comprising spaced raised alignment members for aligning the drug pack component with the iontophoresis patch component;
wherein said alignment structure comprises a multi-panel folding support structure associating said drug pack component said iontophoresis patch component and said separator component.

2. The iontophoretic drug delivery system as in claim 1 wherein said drug pack component and said iontophoresis patch component are provided on separate conjoined panels of said folding support structure.

3. The iontophoretic drug delivery system as in claim 2 wherein said support structures are connected.

4. The iontophoretic drug delivery system as in claim 1 wherein said folding support structure assumes one folded configuration for storage and a different folded configuration for assembly of said system.

5. The iontophoretic drug delivery system as in claim 1 wherein said support structure comprises four conjoined folding panels.

6. The iontophoretic drug delivery system as in claim 1 wherein said drug pack component and said iontophoresis patch component are provided on separate support structures and wherein said alignment structure comprises said guide element associated with at least one of said separate support structures.

7. The iontophoretic drug delivery system as in claim 6 wherein said guide element includes raised alignment members and said separate support structures include corresponding openings to receive said alignment members therethrough.

8. The iontophoretic drug delivery system as in claim 6 wherein one of said separate support structures is attached to said guide element prior to assembly of said system.

9. The iontophoretic drug delivery system as in claim 1 wherein said drug pack component comprises said gel pads including an anode gel pad and a cathode gel pad isolated prior to assembly by a cover membrane having low moisture permeability.

10. The iontophoretic drug delivery system as in claim 9 wherein said gel pads comprise one or more layers of non-woven polymer matrix.

11. The iontophoretic drug delivery system as in claim 9 including an amount of therapeutic agent ion species located in gel associated with at least one of said gel pads.

12. The iontophoretic drug delivery system as in claim 11 wherein said therapeutic agent is present in said gel in a concentration from about 0.2% to 10%.

13. The iontophoretic drug delivery system as in claim 9 wherein said gel pads are fixed to a substrate layer in said drug pack by adherence of a gel material prior to assembly of said system.

14. The iontophoretic drug delivery system as in claim 9 wherein said cover membrane having low moisture permeability comprises a material selected from the group consisting of metal/polymer composites and PVC.

15. The iontophoretic drug delivery system as in claim 1 including an amount of therapeutic species in said iontophoresis patch.

16. The iontophoretic drug delivery system as in claim 1 wherein said iontophoresis patch component includes electrodes comprising an anode and a cathode and a source of electric power.

17. The iontophoretic drug delivery system as in claim 16 wherein said drug pack component comprises said gel pads and said electrodes are contained in recesses adapted to receive said gel pads of said drug pack upon assembly of said system into said assembled state.

18. The iontophoretic drug delivery system as in claim 1 further comprising a peripheral adhesive layer bonding said gel pads to said electrodes in said assembled state.

19. The iontophoretic drug delivery system as in claim 1 wherein the folding support structure comprises three fold lines.

20. The iontophoretic drug delivery system as in claim 19 , wherein each of the three fold lines extends from a first end to a second end of the folding support structure.

21. The iontophoretic drug delivery system as in claim 1 wherein the separator component comprises a fourth panel of the support structure adjacent to the third panel and connected to the third panel by a fold line, and wherein the first panel is connected to the second panel by a fold line, the second panel is connected to the third panel by a fold line.

22. The iontophoretic drug delivery system as in claim 1 wherein the drug pack component comprises a pair of said gel pads on the second panel and wherein the iontophoresis patch component comprises first and second electrodes on the first panel and is configured to align the first and second electrodes respectively with the pair of said gel pads in conductive relation in an assembled state.

23. The iontophoretic drug delivery system as in claim 1 , wherein being associated with comprises being heat-sealed or adhesively attached.

24. The iontophoretic drug delivery system as in claim 23 , wherein the folding support structure comprises a front surface and a back surface, and wherein the iontophoresis patch component is associated with the back surface of the folding support structure and the drug pack component is associated with front surface of the folding support structure.

25. An iontophoretic drug delivery system for pre-use assembly comprising:
(a) a drug pack component comprising one or more gel pads;
(b) an iontophoresis patch component;
(c) wherein said iontophoresis patch component is configured to align with one or more gel pads of said drug pack component in conductive relation in an assembled state; and
(d) an alignment structure to assist in assembling said components, wherein said alignment structure is selected from;
(1) a folding support structure associated with said drug pack component and said iontophoresis patch component, said folding support structure comprising a sepa

Assignees

• Krinke Todd A
• Teva Pharmaceuticals Int Gmbh

Inventors

• Krinke Todd A

Classifications

• A61N1/044

  Shape of the electrode · CPC title

• A61N1/0448 Primary

  Drug reservoir · CPC title

• A61N1/303 Primary

  Constructional details (electrodes for external use A61N1/0428) · CPC title

• A61N1/325

  for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body (electrodes for external use A61N1/0428) · CPC title

• A61N1/30 Primary

  Apparatus for iontophoresis, {i.e. transfer of media in ionic state by an electromotoric force into the body}, or cataphoresis · CPC title